The news last week that the drugmaker Eli Lilly will cap out-of-pocket costs for its insulin at $35 per month brought relief to some.
Read More
Black diabetes patients welcome Eli Lilly’s price cap, but say systemic medical barriers remain

The news last week that the drugmaker Eli Lilly will cap out-of-pocket costs for its insulin at $35 per month brought relief to some.
Read More